HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

TAK 603

potential anti-inflammatory agent; structure given in first source
Also Known As:
TAK-603; ethyl-4-(3,4-dimethoxyphenyl)-6,7-dimethoxy-2-(1,2,4-triazol-1-ylmethyl) quinoline-3-carboxylate; 3-Quinolinecarboxylic acid, 4-(3,4-dimethoxyphenyl)-6,7-dimethoxy-2-(1H-1,2,4-triazol-1-ylmethyl)-, ethyl ester
Networked: 7 relevant articles (2 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Furuichi, Kengo: 1 article (10/2006)
2. Kaneko, Shuichi: 1 article (10/2006)
3. Sakai, Norihiko: 1 article (10/2006)
4. Wada, Takashi: 1 article (10/2006)
5. Yamahana, Junya: 1 article (10/2006)
6. Yokoyama, Hitoshi: 1 article (10/2006)
7. Abe, Shosaku: 1 article (10/2004)
8. Hiraga, Yohmei: 1 article (10/2004)
9. Sato, Noriyuki: 1 article (10/2004)
10. Shigehara, Katsunori: 1 article (10/2004)

Related Diseases

1. Sarcoidosis (Schaumann Disease)
2. Bone Resorption
3. Body Weight (Weight, Body)
4. Rheumatoid Arthritis
5. Experimental Arthritis

Related Drugs and Biologics

1. Transforming Growth Factor beta1 (TGF beta 1)
2. Collagen Type II (Type II Collagen)
3. Interleukin-18 (Interleukin 18)
4. Interleukin-12 (IL 12)
5. Antirheumatic Agents (DMARD)
6. Interleukin-10 (Interleukin 10)
7. Cytokines
8. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
9. Tuberculin (PPD)
10. Messenger RNA (mRNA)

Related Therapies and Procedures

1. Oral Administration